Literature DB >> 10678594

Diuretics as a basis of antihypertensive therapy. An overview.

N M Kaplan1.   

Abstract

Diuretics have been, except for during a few recent years, the most commonly used therapy for hypertension. Although use of these agents fell significantly in the early 1990s, since then it has begun to increase again. Their recent return to popularity reflects 3 major factors: (i) recognition of the effectiveness of much lower dosages than previously used, thereby providing good antihypertensive activity with fewer adverse effects; (ii) the excellent reductions in morbidity and mortality achieved by low dosage diuretic-based therapy in multiple randomised controlled trials in elderly patients with hypertension; and (iii) the increasing recognition that some diuretic-induced shrinkage of effective blood volume is essential for the adequate treatment of many, if not most, patients with hypertension. Therefore, diuretics will probably continue to be the basis for antihypertensive therapy, and the indapamide sustained release 1.5 mg formulation provides all the essential characteristics of diuretic therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678594     DOI: 10.2165/00003495-200059002-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  28 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors:  B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

Review 3.  Review: calcium antagonists and diuretics; a useful combination in the management of hypertension?

Authors:  G Manning; M W Millar-Craig
Journal:  J Hum Hypertens       Date:  1996-07       Impact factor: 3.012

Review 4.  Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension.

Authors:  R R Townsend; O B Holland
Journal:  Arch Intern Med       Date:  1990-06

5.  A comparison of the effects of hydrochlorothiazide and of frusemide in the treatment of hypertensive patients.

Authors:  J Anderson; B E Godfrey; D M Hill; A D Munro-Faure; J Sheldon
Journal:  Q J Med       Date:  1971-10

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial.

Authors:  E P Walma; A W Hoes; C van Dooren; A Prins; E van der Does
Journal:  BMJ       Date:  1997-08-23

Review 8.  Torasemide. An update of its pharmacological properties and therapeutic efficacy.

Authors:  C J Dunn; A Fitton; R N Brogden
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

9.  Diuretic therapy for hypertension and the risk of primary cardiac arrest.

Authors:  D S Siscovick; T E Raghunathan; B M Psaty; T D Koepsell; K G Wicklund; X Lin; L Cobb; P M Rautaharju; M K Copass; E H Wagner
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

10.  Fixed low-dose perindopril-indapamide combination in hypertensive patients with chronic renal failure.

Authors:  A Meyrier; M Dratwa; J Sennesael; V Lachaud-Pettiti
Journal:  Am J Hypertens       Date:  1998-09       Impact factor: 2.689

View more
  6 in total

Review 1.  Use of diuretics in cardiovascular diseases: (1) heart failure.

Authors:  S U Shah; S Anjum; W A Littler
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

Review 2.  Use of diuretics in cardiovascular disease: (2) hypertension.

Authors:  S U Shah; S Anjum; W A Littler
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

3.  Prescribing patterns of diuretics in multi-drug antihypertensive regimens.

Authors:  Hardeep Singh; Michael L Johnson
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738

4.  Angiotensin Converting Enzyme Inhibitors Combined with Exercise for Hypertensive Seniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial.

Authors:  Sara A Harper; Liliana C Baptista; Lisa M Roberts; Sarah J Wherry; Rebecca S Boxer; Kerry L Hildreth; Regina S Seay; P Hunter Allman; Christy S Carter; Inmaculada Aban; Wendy M Kohrt; Thomas W Buford
Journal:  Front Med (Lausanne)       Date:  2020-01-22

5.  Understanding uncontrolled hypertension: is it the patient or the provider?

Authors:  Adam J Rose; Dan R Berlowitz; Michelle B Orner; Nancy R Kressin
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-12       Impact factor: 3.738

6.  Dorzolamide chlorhydrate versus acetazolamide in the management of chronic macular edema in patients with retinitis pigmentosa: description of three case reports.

Authors:  Elena Pacella; Loredana Arrico; Valentina Santamaria; Paolo Turchetti; Maria Rosaria Carbotti; Giuseppe La Torre; Fernanda Pacella
Journal:  Ophthalmol Eye Dis       Date:  2014-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.